Maryland 2025 Regular Session

Maryland House Bill HB572 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2
3	3	EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW.
4	4	[Brackets] indicate matter deleted from existing law.
5	5	hb0572
6	6
7	7	HOUSE BILL 572
8	8	J1 5lr2656
9	9	HB 411/24 – HGO CF 5lr3219
10	10	By: Delegate Kipke
11	11	Introduced and read first time: January 23, 2025
12	12	Assigned to: Health and Government Operations
13	13
14	14	A BILL ENTITLED
15	15
16	16	AN ACT concerning 1
17	17
18	18	Public Health – Opioid Overdose Reversal Drugs 2
19	19
20	20	FOR the purpose of requiring a licensed health care provider, when issuing a standing order 3
21	21	for an opioid overdose reversal drug, to allow an individual to choose any formulation 4
22	22	of any opioid overdose reversal drug approved by the federal Food and Drug 5
23	23	Administration; prohibiting certain private and public entities that prescribe and 6
24	24	dispense opioid overdose reversal drugs from being required to keep in stock or 7
25	25	dispense all opioid overdose reversal drugs approved by the federal Food and Drug 8
26	26	Administration; and generally relating to opioid overdose reversal drugs. 9
27	27
28	28	BY repealing and reenacting, without amendments, 10
29	29	Article – Health – General 11
30	30	Section 13–3101(a), (c), and (e) and 13–3104 12
31	31	Annotated Code of Maryland 13
32	32	(2023 Replacement Volume and 2024 Supplement) 14
33	33
34	34	BY repealing and reenacting, with amendments, 15
35	35	Article – Health – General 16
36	36	Section 13–3106 17
37	37	Annotated Code of Maryland 18
38	38	(2023 Replacement Volume and 2024 Supplement) 19
39	39
40	40	BY adding to 20
41	41	Article – Health – General 21
42	42	Section 13–3110 22
43	43	Annotated Code of Maryland 23
44	44	(2023 Replacement Volume and 2024 Supplement) 24
45	45
46	46	SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 25
47	47	That the Laws of Maryland read as follows: 26
48	48	2 HOUSE BILL 572
49	49
50	50
51	51	Article – Health – General 1
52	52
53	53	13–3101. 2
54	54
55	55	(a) In this subtitle the following words have the meanings indicated. 3
56	56
57	57	(c) “Private or public entity” means a health care provider, local health 4
58	58	department, community–based organization, substance abuse treatment organization, or 5
59	59	other person that addresses medical or social issues related to drug addiction. 6
60	60
61	61	(e) “Standing order” means a written instruction for the prescribing and 7
62	62	dispensing of an opioid overdose reversal drug approved by the federal Food and Drug 8
63	63	Administration in accordance with § 13–3106 of this subtitle. 9
64	64
65	65	13–3104. 10
66	66
67	67	An authorized private or public entity shall enter into a written agreement with a 11
68	68	licensed health care provider with prescribing authority to establish protocols for the 12
69	69	prescribing and dispensing of an opioid overdose reversal drug approved by the federal Food 13
70	70	and Drug Administration to any individual in accordance with this subtitle. 14
71	71
72	72	13–3106. 15
73	73
74	74	(a) A licensed health care provider with prescribing authority may prescribe and 16
75	75	dispense an opioid overdose reversal drug approved by the federal Food and Drug 17
76	76	Administration to an individual who: 18
77	77
78	78	(1) Is believed by the licensed health care provider to be at risk of 19
79	79	experiencing an opioid overdose; or 20
80	80
81	81	(2) Is in a position to assist an individual at risk of experiencing an opioid 21
82	82	overdose. 22
83	83
84	84	(b) (1) A licensed health care provider with prescribing authority may 23
85	85	prescribe and dispense opioid overdose reversal drugs approved by the federal Food and 24
86	86	Drug Administration by issuing a standing order if the licensed health care provider: 25
87	87
88	88	(i) Is employed by the Department or a local health department; or 26
89	89
90	90	(ii) Has a written agreement with an authorized private or public 27
91	91	entity under § 13–3104 of this subtitle. 28
92	92
93	93	(2) WHEN ISSUING A STANDI NG ORDER FOR AN OPIO ID OVERDOSE 29
94	94	REVERSAL DRUG UNDER PARAGRAPH (1) OF THIS SUBSECTION , A LICENSED HEALTH 30
95	95	CARE PROVIDER SHALL ALLOW THE INDIVIDUAL TO CHOOSE ANY FORMUL ATION OF 31
96	96	ANY OPIOID OVERDOSE REVERSAL DRUG APPROV ED BY THE FEDERAL FOOD AND 32
97	97	DRUG ADMINISTRATION . 33 HOUSE BILL 572 3
98	98
99	99
100	100
101	101	[(2)] (3) A licensed health care provider with prescribing authority who 1
102	102	issues a standing order under paragraph (1) of this subsection may delegate the dispensing 2
103	103	of opioid overdose reversal drugs approved by the federal Food and Drug Administration to 3
104	104	an employee or a volunteer of an authorized private or public entity in accordance with a 4
105	105	written agreement under § 13–3104 of this subtitle. 5
106	106
107	107	[(3)] (4) Any licensed health care provider who has dispensing authority 6
108	108	also may dispense an opioid overdose reversal drug approved by the federal Food and Drug 7
109	109	Administration to any individual in accordance with a standing order issued by a licensed 8
110	110	health care provider with prescribing authority in accordance with this subsection. 9
111	111
112	112	(c) A pharmacist may dispense opioid overdose reversal drugs approved by the 10
113	113	federal Food and Drug Administration in accordance with a therapy management contract 11
114	114	under Title 12, Subtitle 6A of the Health Occupations Article. 12
115	115
116	116	13–3110. 13
117	117
118	118	AN AUTHORIZED PRIVATE OR PUBLIC ENTITY THAT PRESCRIBES AND 14
119	119	DISPENSES OPIOID OVE RDOSE REVERSAL DRUGS MAY NOT BE REQUIRED TO KEEP 15
120	120	IN STOCK OR DISPENSE ALL OPIOID OVERDOSE REVE RSAL DRUGS APPROVED BY THE 16
121	121	FEDERAL FOOD AND DRUG ADMINISTRATION . 17
122	122
123	123	SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 18
124	124	October 1, 2025. 19